---
title: " "
pagetitle: "Emily C. Zabor"
---

<link rel="stylesheet" href="styles.css" type="text/css">
<link rel="stylesheet" href="academicicons/css/academicons.min.css"/>

## Invited

2021 International Conference on Statistics for Twenty-First Century, virtual: *Brief Introduction to Phase II Trials in Oncology*

2021 Joint Statistical Meetings, virtual: *Correlating Surrogate Endpoints with Overall Survival at the Individual Patient Level for Precision Oncology* ([slides](https://github.com/zabore/slidedecks/blob/master/Zabor-JSM2021.pdf))

2021 American Urological Association Methods in Clinical Urology Research (MCURe) Workshop, virtual: *Reporting Effect Size and Precision in Clinical Research*

2021 International Indian Statistical Association Conference, virtual: *Bayesian basket trial design with false discovery rate control* ([slides](https://github.com/zabore/slidedecks/blob/master/zabor_iisa2021.pdf))

2020 Greater Cleveland R Group, virtual: *Creating presentation-ready summary tables with {gtsummary}* ([slides](http://www.emilyzabor.com/cleveland-r-gtsummary/#1))

2020 Cleveland Clinic Florida Cancer Grand Rounds, Weston, FL: *Etiologic heterogeneity in cancer*

2018 Memorial Sloan Kettering Cancer Center Department of Epidemiology & Biostatistics, New York, NY: *Statistical methods for the study of etiologic heterogeneity*

2018 Cleveland Clinic Department of Quantitative Health Sciences, Cleveland, OH: *Statistical methods for the study of etiologic heterogeneity*

2018 NYU School of Medicine Department of Population Health, Division of Biostatistics, New York, NY: *Statistical methods for the study of etiologic heterogeneity*

2018 Mayo Clinic Department of Health Sciences Research, Rochester, MN: *Validity of a method for identifying etiologically heterogeneous disease subtypes*

2018 R/Medicine, New Haven, CT: *Teaching Survival Analysis to Clinical Collaborators*

2018 New York R Conference, New York, NY: *How Long Will I Live? The Statistics Behind Prognosis in Cancer Research*


## Contributed

2021 R/Medicine Conference, virtual: *Designing early phase clinical trials with {ppseq}* ([slides](http://www.emilyzabor.com/rmedicine2021))

2018 Joint Statistical Meetings, Vancouver, BC, Canada: *Validity of a method for identifying disease subtypes that are etiologically heterogeneous*

2018 Eastern North American Region of the International Biometric Society, Atlanta, GA: *Validity of a method for identifying disease subtypes that are etiologically heterogeneous*

2017 Joint Statistical Meetings, Baltimore, MD: *Dimension reduction in the study of etiologic heterogeneity*

2017 Society for Epidemiologic Research, Seattle, WA: *A comparison of statistical methods for the study of etiologic heterogeneity* (poster)

2017 Eastern North American Region of the International Biometric Society, Washington DC: *A comparison of statistical methods for the study of etiologic heterogeneity* (poster)

2016 Molecular Pathologic Epidemiology, Boston, MA: *A review of statisitcal methods for evaluating etiologic heterogeneity*

2011 Third North American American Congress of Epidemiology, Montreal, Canada: *Initial reactions to tobacco and risk of future regular tobacco use* (poster)

2010 American Association for Dental Research, Washington DC: *Association between periodontal disease, bacterial vaginosis, and sexual risk behaviours*



